Shopping Cart
Remove All
Your shopping cart is currently empty
SHR-1701 (Synonyms: Retlirafusp alfa)
Catalog No. T73406 Copy Product Info
😃Good
SHR-1701 is a novel bifunctional fusion protein composed of a mAb against programmed death ligand 1 (PD-L1) fused with the extracellular domain of TGFβ receptor II. SHR-1701 has antitumour activity and can be used in solid tumour research.
SHR-1701
Copy Product Info😃Good
Catalog No. T73406
Synonyms Retlirafusp alfa
SHR-1701 is a novel bifunctional fusion protein composed of a mAb against programmed death ligand 1 (PD-L1) fused with the extracellular domain of TGFβ receptor II. SHR-1701 has antitumour activity and can be used in solid tumour research.
SHR-1701
Cas No. 2891860-17-4
Product information is being updated, if you want to purchase, please click the bulk custom button.
Add to Quotation
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Storage & Solubility Information
| Description | SHR-1701 is a novel bifunctional fusion protein composed of a mAb against programmed death ligand 1 (PD-L1) fused with the extracellular domain of TGFβ receptor II. SHR-1701 has antitumour activity and can be used in solid tumour research. |
| Synonyms | Retlirafusp alfa |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Target | PD-L1/TGFβ |
| Cas No. | 2891860-17-4 |
| Storage | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Preview
Related Tags: buy SHR-1701 | purchase SHR-1701 | SHR-1701 cost | order SHR-1701
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.